Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe.
Nikolayevskyy V, Holicka Y, van Soolingen D, van der Werf MJ, Ködmön C, Surkova E, Hillemann D, Groenheit R; ERLTB-Net-2 study participants; Cirillo D. Nikolayevskyy V, et al. Among authors: hillemann d. Eur Respir J. 2021 Jan 5;57(1):2003890. doi: 10.1183/13993003.03890-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 33184119 Free PMC article.
First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries.
Hillemann D, Hoffner S, Cirillo D, Drobniewski F, Richter E, Rüsch-Gerdes S; Baltic-Nordic TB- Laboratory Network; TB PAN-NET; ECDC ERLN-TB Networks. Hillemann D, et al. PLoS One. 2013 Oct 11;8(10):e76765. doi: 10.1371/journal.pone.0076765. eCollection 2013. PLoS One. 2013. PMID: 24146924 Free PMC article.
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirillo DM. Tagliani E, et al. Among authors: hillemann d. J Clin Microbiol. 2015 Sep;53(9):2961-9. doi: 10.1128/JCM.01257-15. Epub 2015 Jul 15. J Clin Microbiol. 2015. PMID: 26179309 Free PMC article.
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.
Domínguez J, Boettger EC, Cirillo D, Cobelens F, Eisenach KD, Gagneux S, Hillemann D, Horsburgh R, Molina-Moya B, Niemann S, Tortoli E, Whitelaw A, Lange C; TBNET; RESIST-TB networks. Domínguez J, et al. Among authors: hillemann d. Int J Tuberc Lung Dis. 2016 Jan;20(1):24-42. doi: 10.5588/ijtld.15.0221. Int J Tuberc Lung Dis. 2016. PMID: 26688526 Review.
External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.
Nikolayevskyy V, Hillemann D, Richter E, Ahmed N, van der Werf MJ, Kodmon C, Drobniewski F, Ruesch-Gerdes S; ERLTB-Net Network. Nikolayevskyy V, et al. Among authors: hillemann d. PLoS One. 2016 Apr 7;11(4):e0152926. doi: 10.1371/journal.pone.0152926. eCollection 2016. PLoS One. 2016. PMID: 27055064 Free PMC article.
93 results